Medicamen Organics IPO will open for subscription from 21 June 2024. The company aims for an issue size of ₹10.54 Cr through this IPO.
Company Overview
| Full name | Medicamen Organics Limited |
| Sector | Healthcaare |
| Industry | Pharmaceuticals & Drugs |
| Company Website | https://www.medicamenorganics.com/ |
About Company
Incorporated in 1995, Medicamen Organics develops, manufactures, and distributes a wide range of pharmaceutical products, including generic tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders for government (including both state and central governments) and private institutions as contract manufacturers / third party manufacturer.
The company’s product list comprises 84 products and offers a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDs). As of 30 September 2023, the company has engaged in contract manufacturing with 38 domestic partners and 12 merchant exporters.
The company products are available in India, as well as in African, CIS, and Southeast Asian countries such as Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan, and Kenya through third-party distributors.
The Objectives of the Issue
- Funding of expenses proposed to be incurred towards Product registration in the international markets;
- Plant updation and increase in production capacity;
- Funding working capital requirements of our Company; and
- General Corporate Purposes.
Medicamen Organics IPO Timetable
| IPO Opening date | 21 June 2024 |
| IPO Closing | 25 June 2024 |
| Basis of Allotment | 26 June 2024 |
| Initiation Refund | 27 June 2024 |
| Credit to Demat Account | 27 June 2024 |
| Listing Date | 28 June 2024 |
Medicamen Organics IPO details
| Issue type | Book Built Issue IPO |
| IPO issue size | ₹10.54 Cr – 3,100,000 shares |
| Fresh Issue | ₹10.54 Cr – 3,100,000 shares |
| Offer for sale | Nil |
| Face value | ₹10 per share |
| Price Band | ₹32 to ₹34 per share |
| Lot size | 4000 Shares |
| Market Maker portion | 172,000 shares |
| Shareholding pre-issue | 8,600,000 |
| Shareholding post-issue | 11,700,000 |
| Listing Exchange | NSE SME |
Medicamen Organics IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4000 | ₹136,000 |
| Retail (Max) | 1 | 4000 | ₹136,000 |
| HNI (Min) | 2 | 8,000 | ₹272,000 |
Medicamen Organics Offer Documents
Medicamen Organics IPO Reservation Details
| Investor Category | Shares Offered |
|---|---|
| Anchor Investor Shares Offered | 876,000 (28.26%) |
| Market Maker Shares Offered | 172,000 (5.55%) |
| QIB Shares Offered | 584,000 (18.84%) |
| NII (HNI) Shares Offered | 440,000 (14.19%) |
| Retail Shares Offered | 1,028,000 (33.16%) |
| Total Shares Offered | 3,100,000 (100%) |
Medicamen Organics Financial Performance
| FY 2022 | FY 2023 | FY 2024 | |
| Revenue | 20.98 | 22.15 | 25.27 |
| Expenses | 20.93 | 21.60 | 21.90 |
| Net income | 0.10 | 0.97 | 2.40 |
Medicamen Organics Valuations & Margins
| FY 2022 | FY 2023 | FY 2024 | |
| EPS | 0.17 | 1.62 | 3.18 |
| PE ratio | – | – | 10.06 – 10.69 |
| RONW (%) | 1.27 | 10.79 | 15.83 |
| NAV | 13.35 | 14.97 | 17.66 |
| ROCE (%) | 3.99 | 9.71 | 14.50 |
| EBITDA (%) | 6.71 | 12.12 | 18.81 |
| Debt/Equity | 0.88 | 1.31 | 0.83 |
Company Promoters
- Mr. Bal Kishan Gupta
Promoter Holding
| Pre Issue Share Holding | 81.21% |
| Post Issue Share Holding |
Medicamen Organics Offer GMP Update
| Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
| 27 June 2024 | 47 | – | 1,51,000 |
| 26 June 2024 | 50 | – | 1,57,000 |
| 25 June 2024 | 50 | – | 1,57,000 |
| 24 June 2024 | 55 | – | 1,70,000 |
| 22 June 2024 | 60 | – | 1,80,000 |
| 21 June 2024 | 60 | – | 1,78,000 |
| 20 June 2024 | 60 | – | 1,75,000 |
| 19 June 2024 | 60 | – | 1,71,000 |
| 18 June 2024 | 57 | – | 1,68,000 |
| 17 June 2024 | 55 | – | 1,60,000 |
Medicamen Organics IPO Subscription Update
| Category | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Shares Offered | 5,84,000 | 4,40,000 | 10,28,000 | 20,52,000 |
| 25 Jun 2024 | 173.03 | 1316.87 | 1116.77 | 891.09 |
| 24 Jun 2024 | 1.42 | 125.05 | 339.69 | 197.39 |
| 21 Jun 2024 | 1.01 | 33.31 | 72.25 | 43.63 |
Medicamen Organics IPO Allotment Status
Medicamen Organics IPO allotment status is now available on the KFin Tech website. Click on this link to get allotment status.
Medicamen Organics IPO Listing Details
| Listing Date | |
| BSE Scrip Code | |
| NSE Symbol | |
| ISIN | |
| Final Issue Price |
Medicamen Organics IPO Listing Day Update
| Listing Exchange | |
| Final Issue Price | |
| Open | |
| Low | |
| High | |
| Last Trade |
Medicamen Organics IPO Lead Manager(s)
GYR CAPITAL ADVISORS PRIVATE LIMITED
428, Gala Empire, Near JB Tower,
Drive in Road, Thaltej, Ahmedabad-380 054
Phone:+91 8777564648
Email: info@gyrcapitaladvisors.com
Website: www.gyrcapitaladvisors.com
Medicamen Organics Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: nvl.ipo@kfintech.com
Website: www.kfintech.com
Medicamen Organics Contact Details
MEDICAMEN ORGANICS LIMITED
10 Community Centre, No 2 Ashok Vihar, Phase II,
New Delhi, Delhi, 110052, India
Phone: +91-9818222845
E-mail: cs@mediorganics.in
Website: www.medicamenorganics.com
Medicamen Organics IPO FAQs
What is the Medicamen Organics offer size?
Medicamen Organics offer size is ₹ 9.92 – 10.54 crores.
What is the Medicamen Organics offer price band?
Medicamen Organics public offer price is ₹ 32 – 34 per share.
What is the lot size of the Medicamen Organics Offer?
Medicamen Organics offer a lot size is 4,000 shares.
What is Medicamen Organics Offer GMP today?
Medicamen Organics IPO GMP today is ₹ 47 per share.
What is the Medicamen Organics kostak rate today?
Medicamen Organics kostak rate today is ₹ NA per application.
What is Medicamen Organics Subject to the Sauda rate today?
Medicamen Organics is Subject to the Sauda rate today is ₹ 1,51,000 per application.
Final thoughts
Medicamen Organics IPO is going to hit Dalal Street soon. applying for an IPO is purely a personal choice. Study the company well and subscribe if you feel good about it. I hope this post will give you enough details to research the company fundamentally. learn well and make wise decisions.
Happy Investing
